OrganogenesisORGO
Price
$ 2.47
Market Capitalization
$ 327.46 M
Shares Outstading
132.575 M
Change
$ -0.17
Percentage Change
-6.44 %
Country
United States 🇺🇸
Industry
Drug Manufacturers—Specialty & Generic
Healthcare
Exchange
NASDAQ Capital Market
IPO
2017-01-05
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound coveri
Market Capitalization of Organogenesis ( ORGO)
Market Capitalization : $ 327.46 Million
Organogenesis has Market Capitalization of $ 327.46 Million .The current price of Organogenesis is $2.47 (-6.44 %). Market capitalization, commonly referred to as market cap, represents the total market value of a publicly traded company's outstanding shares and serves as a widely used metric for assessing a company's overall worth.
Market Capitalization of Organogenesis from 2017 to 2024
Year on Year Market Capitalization of Organogenesis
| Year | Market Capitalization | Change % |
|---|---|---|
| 06-01-2024 | $ 552.83 M | 59.96% |
| 07-01-2023 | $ 345.60 M | -70.93% |
| 01-01-2022 | $ 1.19 B | 18.73% |
| 04-01-2021 | $ 1.00 B | 113.57% |
| 31-01-2020 | $ 468.80 M | -65.1% |
| 31-01-2019 | $ 1.34 B | 335.36% |
| 31-01-2018 | $ 308.50 M | 0.72% |
| 31-01-2017 | $ 306.30 M |
Market Cap of Magnificent 7
Stock Ticker | Market Cap | Price | Change | Price(30 Days) | Country |
|---|---|---|---|---|---|
$ 3.357 T | $ 220.82 -0.70% | $ -1.56 | United States🇺🇸 | ||
$ 2.986 T | $ 401.7 -1.64% | $ -6.69 | United States🇺🇸 | ||
$ 2.522 T | $ 102.83 -4.09% | $ -4.38 | United States🇺🇸 | ||
$ 1.864 T | $ 152.13 -4.08% | $ -6.47 | United States🇺🇸 | ||
$ 1.799 T | $ 171.39 -3.65% | $ -6.5 | United States🇺🇸 | ||
$ 1.776 T | $ 7.3453 0.00% | $ 0 | Saudi Arabia🇸🇦 | ||
$ 1.266 T | $ 500.27 -3.21% | $ -16.59 | United States🇺🇸 |
